Senior insider sale
President and CEO at KYMERA THERAPEUTICS, INC. — senior position signals high conviction
$15.17M
130K shares
What this filing means
MAINOLFI NELLO plans to sell 130K shares of KYMERA THERAPEUTICS, INC. valued at approximately $15.17M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/7/2026ACC: 0001969223-26-000769
DirectorOfficer· President and CEO
Since Aug 2020
130K
Shares to sell
$15.17M
Approx. market value
50K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Exercise of stock options
Cash
7/7/2026
50KTotal acquired50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/7/2026 | Exercise of stock options Cash | 50K | — |
| Total | 50K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
80K
Market value
$9.22M
7/1/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
50K
Market value
$5.95M
7/7/2026
Total
Units
130K
Value
$15.17M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/1/2026 | 80K | $9.22M | — | Completed |
| Planned — Approximate Date | ||||
7/7/2026 | 50K | $5.95M | NASDAQ | Planned |
| Total | 130K | $15.17M | ||